Company Cyclacel Pharmaceuticals Inc Nasdaq
Equities
US23254L3069
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
06-26 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
06-26 | Sector Update: Health Care Stocks Lower in Afternoon Trading | MT |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cancer Medicines
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Spiro Rombotis
CEO | Chief Executive Officer | 65 | 31/07/97 |
Paul McBarron
DFI | Director of Finance/CFO | 63 | 31/12/01 |
Brian Schwartz
CTO | Chief Tech/Sci/R&D Officer | 52 | 16/12/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 83 | 28/02/06 | |
Brian Schwartz
CTO | Chief Tech/Sci/R&D Officer | 52 | 16/12/20 |
Spiro Rombotis
CEO | Chief Executive Officer | 65 | 31/07/97 |
Paul McBarron
DFI | Director of Finance/CFO | 63 | 31/12/01 |
Robert Spiegel
BRD | Director/Board Member | 73 | 11/09/18 |
Samuel Barker
CHM | Chairman | 81 | 10/09/14 |
Kenneth Ferguson
BRD | Director/Board Member | 68 | 13/06/22 |
Karin Walker
BRD | Director/Board Member | 60 | 08/11/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 264 | 0 | 0 | 75.37 % |
Stock B | 1 | 1,463,259 | 1,355,555 ( 92.64 %) | 0 | |
Stock C | 0 | 335,273 | 0 | 0 |
Company contact information
Cyclacel Pharmaceuticals, Inc.
200 Connell Drive Suite 1500
07922, Berkeley Heights
+908 517 7330
http://www.cyclacel.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+20.03% | 126B | |
+23.61% | 117B | |
+23.26% | 27.52B | |
-18.07% | 20.87B | |
-15.13% | 17.01B | |
-14.81% | 16.26B | |
+9.78% | 14.56B | |
-46.10% | 15.09B | |
+52.34% | 13.89B |
- Stock Market
- Equities
- CYCC Stock
- Stock
- Company Cyclacel Pharmaceuticals Inc